Radiotracer imaging using sodium iodide symporter polypeptides
AssigneeMayo Foundation for Medical Education and Research
InventorsStephen James Russell, Kah-Whye Peng, Patrycja Lech
Life of this patent
Estimating the term…
Abstract
This document provides methods and materials involved in radiotracer imaging using NIS polypeptides. For example, methods and materials for performing imaging techniques that increase the detection sensitivity and resolution of radiotracers localized by NIS reporter gene expression and/or decrease background signals that can be attributed to endogenously expressed NIS polypeptides are provided.
Claims20
A method of imaging an animal comprising cells expressing a NIS transgene, wherein said method comprises:
- (a) administering two or more gamma-emitting NIS radiotracers to said animal,
- (b) collecting imaging data during a single imaging session using at least two energy windows that distinguish the gamma emissions of said two or more radiotracers to obtain at least two gamma emission datasets,
- (c) subtracting one of said at least two gamma emission datasets from another of said at least two gamma emission datasets to obtain a resulting dataset capable of being used to generate subtraction images for visual or other analysis.
A method of imaging an animal comprising cells expressing a NIS transgene, wherein said method comprises:
- (a) administering a gamma-emitting or positron-emitting NIS radiotracer to said animal,
- (b) administering non-radioactive perchlorate anions to said animal in a dose sufficient to substantially inhibit the uptake of said radiotracer by endogenous NIS-expressing cells, and
- (c) collecting imaging data from said animal.
A method for imaging a mammal to reduce background from cells endogenously expressing a wild type NIS polypeptide within the stomach of said mammal, wherein said method comprises obtaining an image of radioisotope signals from a radioisotope present within said mammal, wherein said image is obtained within four hours of said mammal ingesting a contrast agent, wherein cells outside the stomach of said mammal expressing a NIS polypeptide uptake said radioisotope.
A method for imaging a mammal to reduce background from radioisotope signals from cells endogenously expressing a wild-type NIS polypeptide, wherein said mammal comprises cells endogenously expressing said wild-type NIS polypeptide and cells expressing a mutant NIS polypeptide, wherein said method comprises:
- (a) obtaining a first image of radioisotope signals from a first radioisotope present within a mammal, wherein cells endogenously expressing said wild-type NIS polypeptide within said mammal uptake said first radioisotope to a greater extent than cells expressing said mutant NIS polypeptide,
- (b) obtaining a second image of radioisotope signals from a second radioisotope present within a mammal, wherein cells endogenously expressing said wild-type NIS polypeptide within said mammal and cells expressing said mutant NIS polypeptide within said mammal uptake said second radioisotope, and
- (c) removing radioisotope signals of said first image from the radioisotope signals of said second image to obtain a final image.
Dependencies are inferred from the claim text.